Mogamulizumab-kpkc Intravenous and Pioglitazone and Metformin Extended-Release Tablets
Determining the interaction of Mogamulizumab-kpkc Intravenous and Pioglitazone and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: metformin / pioglitazone
Brand name: Actoplus Met, Actoplus Met XR
Synonyms: Metformin and pioglitazone, Pioglitazone and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Pioglitazone and Metformin Tablets
- Mogamulizumab-kpkc Intravenous-Pioglitazone Hydrochloride
- Mogamulizumab-kpkc Intravenous-Pioglitazone Tablets
- Mogamulizumab-kpkc Intravenous-Piperacillin
- Mogamulizumab-kpkc Intravenous-Piperacillin and tazobactam
- Mogamulizumab-kpkc Intravenous-Piperacillin and tazobactam Intravenous
- Pioglitazone and Metformin Extended-Release Tablets-Molindone
- Pioglitazone and Metformin Extended-Release Tablets-Mometasone (Oral Inhalation)
- Pioglitazone and Metformin Extended-Release Tablets-Mometasone and Formoterol
- Pioglitazone and Metformin Extended-Release Tablets-Mometasone and formoterol Inhalation
- Pioglitazone and Metformin Extended-Release Tablets-Mometasone Cream
- Pioglitazone and Metformin Extended-Release Tablets-Mometasone Furoate